Read more

April 01, 2020
1 min read
Save

Top 5 psychiatry stories of March

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Healio Psychiatry has compiled a list of its top five most-viewed stories in March.

A Q&A on calming COVID-19 anxiety, research into the link between widowhood and cognitive decline and a study of female physicians’ suicide mortality rate were just some of the most-read stories on Healio Psychiatry for the month.

Which story resonated with you most? Leave a comment or write to us on Twitter @HealioPsych.

Q&A: Accurate information from reliable sources key in calming COVID-19 anxiety

Healio Psychiatry spoke with Vinay Saranga, MD, founder of Saranga Comprehensive Psychiatry, about the mental health impact of COVID-19 and how clinicians can help their patients manage anxiety amid the outbreak. Read more.

Widowhood, Alzheimer's disease biomarker linked to cognitive decline among older adults

Widowhood may accelerate cognitive decline and Alzheimer’s disease clinical progression, according to a study published in JAMA Network Open. Read more.

Female physicians have higher suicide mortality rate than male physicians, women in general

Since 1980, suicide standardized mortality ratios have been high among female physicians and low among male physicians, according to findings of a systematic review and meta-analysis published in JAMA Psychiatry. However, these ratios decreased over time in both groups. Read more.

Alcoholics Anonymous more effective than established treatments for alcohol use disorder

Alcoholics Anonymous appeared to be the most effective route for treating alcohol use disorder, according to study results published in Cochrane Database of Systematic Reviews. Read more.

FDA grants breakthrough designation to transcranial magnetic stimulation device for bipolar depression

The FDA granted breakthrough device designation to the NeuroStar Advanced Therapy System for the treatment of bipolar depression, according to a press release from Neuronetics Inc., the device’s manufacturer. Read more